+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report by Component (Pumps, Oxygenators), by Modality, by Application (Respiratory, Cardiac), by Patient Type, and Segment Forecasts, 2020 - 2027

  • ID: 4778237
  • Report
  • February 2020
  • Region: Global
  • 110 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Maquet Holding
  • Medos Medizintechnik
  • Medtronic Plc
  • Nipro Medical Corporation
  • Sorin Group (Sorin S.P.A)
  • MORE
The global extracorporeal membrane oxygenation machine market size is expected to reach USD 394.9 million by 2027, according to this report registering a CAGR of 4.5% over the forecast period. The market is primarily driven by increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of extracorporeal membrane oxygenation (ECMO) procedures. Cardiovascular disease is one of the leading causes of death globally. According to WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Increasing awareness about ECMO procedures, coupled with various government initiatives, are further propelling the market for extracorporeal membrane oxygenation machines.

Increasing survival rate of cardiac and respiratory patients undergoing ECMO machine-supported surgery is also driving the ECMO machine market. Application of extracorporeal membrane oxygenation machine in procedures has increased over the years. This machine was traditionally used in cases of circulatory or respiratory failure. However, its applications have expanded to be used as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure. The use of extracorporeal membrane oxygenation machines has been rising gradually worldwide owing to its benefits such as acting as an artificial lung for patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities are fueling the market for extracorporeal membrane oxygenation machines. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030, rising from USD 320 billion in 2011.

Further key findings from the report suggest:
  • by component, the oxygenators segment accounted for the leading revenue share in 2019 owing to its high cost and usage
  • Based on modality, veno-arterial ECMO machines held the dominant market share in 2019 and is also expected to register the fastest growth rate during the forecast period
  • On the basis of patient type, the adult segment is likely to exhibit a rapid pace over the course of the forecast period owing to rising incidence of cardiac and pulmonary diseases
  • The respiratory application segment emerged as the leading revenue contributor in the ECMO machine market in 2019 and is also expected to grow at the fastest rate
  • North America accounted for the largest share in 2019 owing to favorable reimbursement policies, presence of key players, and government initiatives
  • Leading players in the extracorporeal membrane oxygenation machines market include Nipro Medical Corporation Medtronic plc, Microport Scientific Corporation, Sorin Group, MAQUET Holding B.V. & Co. KG, Terumo Cardiovascular Systems Corporation, and Medos Medizintechnik AG. Major players are focusing on technological collaborations and product launches to stay ahead.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Maquet Holding
  • Medos Medizintechnik
  • Medtronic Plc
  • Nipro Medical Corporation
  • Sorin Group (Sorin S.P.A)
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Modality
1.1.3. Patient Type
1.1.4. By Application
1.1.5. Country scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Modality outlook
2.2.3. Patient type outlook
2.2.4. Application outlook
2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. ECMO Machine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of cardiopulmonary and respiratory diseases
3.4.1.2. Increasing adoption of ECMO machines in hospitals
3.4.1.3. Technological advancement in ECMO machines
3.4.1.4. Growing awareness towards the application of ECMO
3.4.2. Market restraint analysis
3.4.2.1. High cost of procedures
3.4.2.2. Risk of complications during ECMO procedures
3.4.2.3. Presence of conventional technique
3.4.3. Industry challenges
3.5. ECMO Machine Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies

Chapter 4. ECMO Machine Market by Component Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Pumps
4.1.2. Oxygenator
4.1.3. Controllers
4.1.4. Cannula
4.1.5. Accessories
4.2. Product Market Share, 2019 & 2027
4.3. Segment Dashboard
4.4. Global ECMO Machine Market by Component Outlook
4.4.1. Pumps
4.4.1.1. Pump market estimates and forecast, 2016 - 2027 (USD Million)
4.4.2. Oxygenator
4.4.2.1. Oxygenator market estimates and forecast, 2016 - 2027 (USD Million)
4.4.3. Controllers
4.4.3.1. Controllers market estimates and forecast, 2016 - 2027 (USD Million)
4.4.4. Cannula
4.4.4.1. Cannula market estimates and forecast, 2016 - 2027 (USD Million)
4.4.5. Accessories
4.4.5.1. Accessories market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 5. ECMO Machine Market: By Modality Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Veno-Arterial
5.1.2. Veno-Venous
5.1.3. Arterio-Venous
5.2. By Modality Market Share, 2019 & 2027
5.3. Segment Dashboard
5.4. Global ECMO Machine Market by Modality Outlook
5.4.1. Veno-Arterial
5.4.1.1. Veno-Arterial market estimates and forecast, 2016 - 2027 (USD Million)
5.4.2. Veno-Venous
5.4.2.1. Veno-Venous market estimates and forecast, 2016 - 2027 (USD Million)
5.4.3. Arterio-Venous
5.4.3.1. Arterio-Venous market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6. ECMO Machine Market: By Patient Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Neonates
6.1.2. Pediatric
6.1.3. Adult
6.2. Patient Type Market Share, 2019 & 2027
6.3. Segment Dashboard
6.4. Global ECMO machine market by Patient Type Outlook
6.4.1. Neonates
6.4.1.1. Neonates market estimates and forecast, 2016 - 2027 (USD Million)
6.4.2. Pediatric
6.4.2.1. Pediatric market estimates and forecast, 2016 - 2027 (USD Million)
6.4.3. Adult
6.4.3.1. Adult market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7. ECMO machine Market: By Application Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Respiratory
7.1.2. Cardiac
7.1.3. ECPR
7.2. Application Market Share, 2019 & 2027
7.3. Segment Dashboard
7.4. Global ECMO machine Market by application Outlook
7.4.1. Respiratory
7.4.1.1. Respiratory market estimates and forecast, 2016 - 2027 (USD Million)
7.4.1.2. Respiratory market estimates and forecast, by patient type 2016 - 2027 (USD Million)
7.4.1.2.1. Neonates
7.4.1.2.2. Pediatric
7.4.1.2.3. Adult
7.4.2. Cardiac
7.4.2.1. Cardiac market estimates and forecast, 2016 - 2027 (USD Million)
7.4.2.2. Cardiac market estimates and forecast, by patient type 2016 - 2027 (USD Million)
7.4.2.2.1. Neonates
7.4.2.2.2. Pediatric
7.4.2.2.3. Adult
7.4.3. ECPR
7.4.3.1. ECPR market estimates and forecast, 2016 - 2027 (USD Million)
7.4.3.2. ECPR market estimates and forecast, by patient type 2016 - 2027 (USD Million)
7.4.3.2.1. Neonates
7.4.3.2.2. Pediatric
7.4.3.2.3. Adult

Chapter 8. ECMO Machine Market: Country Estimates & Trend Analysis
8.1. Country Market Share Analysis, 2019 & 2027
8.2. County Market Dashboard
8.3. Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2019
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
8.7. North America
8.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.7.2. U.S.
8.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
8.7.3. Canada
8.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
8.8. Europe
8.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.8.2. U.K.
8.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
8.8.3. Germany
8.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
8.8.4. France
8.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
8.8.5. Italy
8.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
8.8.6. Spain
8.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
8.8.7. Czech Republic
8.8.7.1. Czech Republic market estimates and forecast, 2016 - 2027 (USD Million)
8.8.8. Russia
8.8.8.1. Russia market estimates and forecast, 2016 - 2027 (USD Million)
8.8.9. Poland
8.8.9.1. Poland market estimates and forecast, 2016 - 2027 (USD Million)
8.8.10. Turkey
8.8.10.1. Turkey market estimates and forecast, 2016 - 2027 (USD Million)
8.8.11. Switzerland
8.8.11.1. Switzerland market estimates and forecast, 2016 - 2027 (USD Million)
8.9. Asia Pacific
8.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.9.2. Japan
8.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
8.9.3. China
8.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
8.9.4. India
8.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
8.9.5. Australia
8.9.5.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
8.9.6. South Korea
8.9.6.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
8.9.7. Vietnam
8.9.7.1. Vietnam market estimates and forecast, 2016 - 2027 (USD Million)
8.9.8. Philippines
8.9.8.1. Philippines market estimates and forecast, 2016 - 2027 (USD Million)
8.9.9. Malaysia
8.9.9.1. Malaysia market estimates and forecast, 2016 - 2027 (USD Million)
8.9.10. Indonesia
8.9.10.1. Indonesia market estimates and forecast, 2016 - 2027 (USD Million)
8.9.11. Thailand
8.9.11.1. Thailand market estimates and forecast, 2016 - 2027 (USD Million)
8.10. Latin America
8.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.10.2. Brazil
8.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
8.10.3. Mexico
8.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
8.10.4. Colombia
8.10.4.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
8.10.5. Argentina
8.10.5.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
8.10.6. Chile
8.10.6.1. Chile market estimates and forecast, 2016 - 2027 (USD Million)
8.11. Middle East & Africa
8.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
8.11.2. South Africa
8.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
8.11.3. Saudi Arabia
8.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
8.11.4. UAE
8.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)
8.11.5. Oman
8.11.5.1. Oman market estimates and forecast, 2016 - 2027 (USD Million)
8.11.6. Kuwait
8.11.6.1. Kuwait market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2019
9.3.4. Medtronic Plc
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Procedure benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Maquet Holding
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Procedure benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Microport Scientific Corporation
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Procedure benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Terumo Cardiovascular System Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Procedure benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Medos Medizintechnik
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Procedure benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Nipro Medical Corporation
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Procedure benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Sorin Group (Sorin S.P.A)
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Procedure benchmarking
9.3.10.4. Strategic initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3
  • Medtronic Plc
  • Maquet Holding
  • Microport Scientific Corporation
  • Terumo Cardiovascular System Corporation
  • Medos Medizintechnik
  • Nipro Medical Corporation
  • Sorin Group (Sorin S.P.A)
Note: Product cover images may vary from those shown
Adroll
adroll